Long-term trends in intraocular pressure after combined vitrectomy with sub-tenon injection of triamcinolone acetonide.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 25170861.
- Also identified by DOI 10.1097/IAE.0000000000000333.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To evaluate the long-term effect of vitrectomy by itself and combined vitrectomy with sub-Tenon injection of triamcinolone acetonide (TA) on intraocular pressure (IOP). In a retrospective cohort study, the medical records of 56 eyes of 56 patients who underwent nonemergent vitrectomy and were followed up for at least 24 months were reviewed. Thirty-two eyes of 32 patients underwent combined vitrectomy with sub-Tenon injection of TA. Twenty-four eyes of 24 patients underwent vitrectomy only. Increased IOP of >4 mmHg from the baseline, change in IOP from the baseline, and preoperative and postoperative measured IOPs were recorded and compared between the two groups, and with fellow eyes. Minimum follow-up period was 24 months. Except the IOP at postoperative 1 day, there were no significant differences between vitrectomized eyes and nonvitrectomized fellow eyes. There were also no differences between vitrectomized eyes and eyes that underwent combined vitrectomy with sub-Tenon injection of TA. And in the comparison of the vitrectomy-only eye group and the vitrectomy with sub-Tenon TA eye group, there was also no significant difference during the whole follow-up period. Vitrectomy by itself or combined vitrectomy with sub-Tenon injection of TA does not seem to increase IOP in the long term.
Medical subject headings
- Glucocorticoids
- Intraocular Pressure
- Tenon Capsule
- Triamcinolone Acetonide
- Vitrectomy